Postpartum thyroiditis screening: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Sunny Kumar (talk | contribs) |
||
Line 16: | Line 16: | ||
==Screening== | ==Screening== | ||
*There is insufficient evidence to recommend routine screening for | *There is insufficient evidence to recommend routine screening for PPT, | ||
*According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: | |||
*According to | *Type 1 DM | ||
*History of postpartum thyroiditis | |||
*According to the | |||
*According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women. | |||
==References== | ==References== |
Revision as of 00:42, 30 September 2017
Postpartum thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postpartum thyroiditis screening On the Web |
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for PPT,
- According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with:
- Type 1 DM
- History of postpartum thyroiditis
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.